New York State Common Retirement Fund’s Nuvectis Pharma NVCT Stock Holding History

New York State Common Retirement Fund’s Portfolio NVCT Stock Details NVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92K	Hold	5,000	–	–	﹤0.01%	2746
2026 Q1	$38.6K	Hold	5,000	–	–	﹤0.01%	2889
2025 Q4	$37.8K	Hold	5,000	–	–	﹤0.01%	2979
2025 Q3	$30.1K	Sell	5,000 -8,000	-62%	-$55K	﹤0.01%	3054
2025 Q2	$97.1K	Buy	+13,000	New	+$118K	﹤0.01%	2693
2024 Q3	–	Sell	-64	Closed	-$405	–	3296
2024 Q2	$405	Sell	64 -5,685	-99%	-$38.6K	﹤0.01%	3351
2024 Q1	$47.1K	Sell	5,749 -23	-0.4%	-$196	﹤0.01%	2997
2023 Q4	$48.1K	Hold	5,772	–	–	﹤0.01%	3010
2023 Q3	$74.4K	Buy	5,772 +72	+1%	+$1.04K	﹤0.01%	2866
2023 Q2	$91K	Buy	+5,700	New	+$91K	﹤0.01%	2934

Other funds holding NVCT

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCM

Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

New York State Common Retirement Fund's NVCT Position: Q2 2026 in Review

New York State Common Retirement Fund held its Nuvectis Pharma (NVCT) position steady in Q2 2026 at 5,000 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

New York State Common Retirement Fund first reported a position in NVCT in Q2 2023 and has held it in 10 quarters since. The position peaked at $97.1K in Q2 2025. 82 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

New York State Common Retirement Fund held 5,000 shares of Nuvectis Pharma worth $92K as of Q2 2026.
New York State Common Retirement Fund left its Nuvectis Pharma share count unchanged in Q2 2026.
Nuvectis Pharma made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2746 holding.
New York State Common Retirement Fund first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 10 quarters since.
New York State Common Retirement Fund's Nuvectis Pharma position peaked at $97.1K in Q2 2025.
82 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.